LBO ‐06: Retreatment with Sofosbuvir/Velpatasvir/Voxilaprevir for 12 weeks is safe and effective for patients who have previously received Sofosbuvir/Velpatasvir or Sofosbuvir/Velpatasvir/Voxilaprevir

Journal of Viral Hepatitis,Volume 25, Issue S2, Page 193-193, June 2018.

Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research